| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/12/2009 | US7531723 Transformation of cells with a genetic construct capable of regulating gene expression in developing seed or female reproductive tissue; enhanced vigor, improved stress tolerance and yield stability |
| 05/12/2009 | US7531721 Soybean cultivar 6044483 |
| 05/12/2009 | US7531720 Soybean cultivar S050224 |
| 05/12/2009 | US7531718 Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 05/12/2009 | US7531717 Comprises nucleotide sequences coding proanthocyanidins for use as biosynthetic tools in agriculture, land reclamation animal farming and food processing |
| 05/12/2009 | US7531716 Materials and methods for producing tomato yellow leaf curl virus resistance in plants |
| 05/12/2009 | US7531715 Method of reconstituting an animal embryo, the process comprising transferring a nucleus into a first oocyte followed by removing and transferring the nucleus from the oocyte to a further oocyte or to enucleated fertilized zygote; may be used to introduce genetic modifications into resultant offspring |
| 05/12/2009 | US7531714 Non-human transgenic animals as model study for human pathologies, being transgenic for having altered melusin expression; the non-human transgenic animals are to be used to study heart pathologies and provide therapies thereof, wherein heart pathologies are heart failure, and diluted cardiomyopathy |
| 05/12/2009 | US7531713 Assay for toxin induced neuronal degeneration and viability in C. elegans |
| 05/12/2009 | US7531712 P450 gene regulation |
| 05/12/2009 | US7531649 Methods that allow the identification of aptamers to receptor tyrosine kinases such as HER3 as well as specific aptamers that recognize these molecules |
| 05/12/2009 | US7531648 Gene therapy |
| 05/12/2009 | US7531647 Expression vector comprising nucleotide sequences coding fusion protein comprising HIV preintegration protein Vpr attached to amino or carboxy terminus of the Cre recombinase for use as genetic transfer tool in gene therapeutics |
| 05/12/2009 | US7531642 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 05/12/2009 | US7531641 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531640 Immunoglobulin specific for lymphadenopathy associated viral epitopes p24 and p26 for use as disgnostic tool in detection of viral disease |
| 05/12/2009 | US7531639 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531638 Monoclonal antibodies that recognize a shared epitope between the human immunodeficiency virus type 1 (HIV-1) capsid (CA/p24) and the human immunodeficiency virus type 2 (HIV-2) capsid (CA/p26) |
| 05/12/2009 | US7531636 A proinflammatory cytokine; monoclonal antibodies, or mixture of polyclonal antibodies; blocks signal transduction; hematopoietic cell proliferation |
| 05/12/2009 | US7531635 Monoclonal antibodies or functional fragment; immunoassay kit; female fertility diagnosis; Premature ovarian failure |
| 05/12/2009 | US7531629 Tumor associated antigen peptides and use of same as anti-tumor vaccines |
| 05/12/2009 | US7531626 Tenebrio antifreeze proteins |
| 05/12/2009 | US7531625 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders |
| 05/12/2009 | US7531530 derivatives of tricyclic lactam indoles and tricyclic lactam benzimidazoles; poly (ADP-ribose) polymerase (PARP) inhibitors; breast cancer, cancers caused by genetic defect in a gene; side effects reduction by not administering as a combination therapy; low doses; antiapoptosis; BRCA1 or BRCA2 expression |
| 05/12/2009 | US7531524 For host undergoing surgery or coronary artery bypass |
| 05/12/2009 | US7531523 Recombinant nucleic acid encoding a human sodium channel NaV1.3 polypeptide; diagnostic kit for detecting a nucleic acid that encodes the polypeptide |
| 05/12/2009 | US7531522 Polynucleotide with a sequence coding for a fusion protein that is an anti-fungal protein or peptide and an antibody FV fragment specifically recognising an epitope of an Ascomyceta, and a cellular targeting signal |
| 05/12/2009 | US7531516 Antiinflammatory agents; multiple sclerosis; inflamamtory bowel disorders; antitumor agents; sepsis |
| 05/12/2009 | US7531515 Cancer treatment by administration of a synthetic peptide comprising a sequence of amino acids within the p53 protein and a membrane penetrating leader sequence |
| 05/12/2009 | US7531509 Cationic peptide that inhibits the growth of both grampositive and/or gramnegative bacteria; isolated from the hemocytes of the sea squirt; can be used to treat antibiotic resistant tuberculosis, pneumonia, and urinary pathologies |
| 05/12/2009 | US7531504 Peptide antagonists of zonulin that bind to the zonula occludens receptor, yet do not physiologically modulate the opening of mammalian tight junctions; tablets, capsules |
| 05/12/2009 | US7531356 exposing host cells in vitro that comprising genetic vector consisting a polynucleotide and a heterologous reporter gene operably linked to the polynucleotide, to test agents, then measuring and comparing the reporter gene expression level to that of a control cell that is not exposed to the test agent |
| 05/12/2009 | US7531353 Non self-inactivating, expression targeted retroviral vectors |
| 05/12/2009 | US7531352 Inducible plasmid vector encoding TGF-β and use thereof |
| 05/12/2009 | US7531348 Recombinant yeast for lignocellulose raw materials |
| 05/12/2009 | US7531347 Methods and compositions for synthesis of long chain polyunsaturated fatty acids |
| 05/12/2009 | US7531342 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences |
| 05/12/2009 | US7531340 Peptide-forming enzyme gene |
| 05/12/2009 | US7531339 Glyphosate-N-acetyltransferase (GAT) genes |
| 05/12/2009 | US7531336 Methods for producing recombinant histidine-tagged inosine nonophosphate dehydrogenase polypeptides |
| 05/12/2009 | US7531335 Modified cytochrome p450 monooxygenases |
| 05/12/2009 | US7531333 Process for producing isoprenoid compounds by microorganisms and a method for screening compounds with antibiotic or weeding activity |
| 05/12/2009 | US7531332 esterifying L-PHE to generate a lower alkyl ester of L-phenylalanine, condensing the lower alkyl ester of L-phenylalanine with N-acyl-L-aspartic anhydride to obtain a lower alkyl ester of N-acyl- alpha -L-aspartyl-L-phenylalanine, separating, hydrogenating to form lower alkyl ester of alpha ASP-PHE |
| 05/12/2009 | US7531331 Butynol I esterase |
| 05/12/2009 | US7531330 Heat resistant lyase for use in producing optically active cyanohydrins; drug design |
| 05/12/2009 | US7531329 Carbonyl reductase, gene thereof and method of using the same |
| 05/12/2009 | US7531328 Methods and devices for multiplexing amplification reactions |
| 05/12/2009 | US7531326 Chimeric retinoid X receptors and their use in a novel ecdysone receptor-based inducible gene expression system |
| 05/12/2009 | US7531325 Preparing genetically engineered polypeptides/zymogens for pharmaceutical or food composition |
| 05/12/2009 | US7531324 Interferon-alpha polypeptides and conjugates |
| 05/12/2009 | US7531322 Using tissue specific gene transfer element as tool in somatic gene therapy |
| 05/12/2009 | US7531321 Fibroblast growth factor-like molecules and uses thereof |
| 05/12/2009 | US7531320 Modulation of β-catenin/TCF-activated transcription |
| 05/12/2009 | US7531317 Fluorescence polarization assay to detect protease cleavage |
| 05/12/2009 | US7531316 complexing a radiolabeled platelet-activating factor (PAF) with a sequestering molecule comprising exogenous albumin, to form a PAF-sequester molecule complex, then determining lipoprotein-associated phospholipase A2 (Lp-PLA2) enzyme activity in samples, by measuring the cleavage of the complex |
| 05/12/2009 | US7531308 Process for the reduction of endotoxins in a plasmid preparation using a carbohydrate non-ionic detergent with silica chromatography |
| 05/12/2009 | US7531307 Use of representations of DNA for genetic analysis |
| 05/12/2009 | US7531304 Method for screening FGFR-4 agonists |
| 05/12/2009 | US7531302 Nucleic acid detection method by triple helix formation |
| 05/12/2009 | US7531182 Vaccine against foot-and-mouth disease |
| 05/12/2009 | US7531180 Chimeric alphavirus replicon particles |
| 05/12/2009 | US7531176 Brachyspira pilosicoli 72 kDa outer-membrane protein and diagnostic and therapeutic uses thereof |
| 05/12/2009 | US7531175 Methods for modulation of immune responses using humanized immunoglobulins reactive with B7-1 molecules |
| 05/12/2009 | US7531174 for in vitro diagnostics/antitumor agents; gene overexpression of cell surface proteins; genetic engineering; |
| 05/12/2009 | US7531173 Ophthalmic composition comprising vascular endothelial growth factor antagonist for use in prevention and treatment of vision defects |
| 05/12/2009 | US7531172 administering vascular endothelial growth factor (VEGF) inhibitors, to reduce or prevent hypertension |
| 05/12/2009 | US7531169 or an antigen binding fragment comprising variable light chain region and heavy chain peptides, directed against isotypic determinants of immunoglobulin E (IgE), useful for diagnostics, prophylaxis and treatment of disease such as asthma, rhinitis, eczema, urticaria. dermatitis or food allergies |
| 05/12/2009 | CA2415749C Method of producing infectious reovirus |
| 05/12/2009 | CA2400143C Recombinant conglutinin and producing method thereof |
| 05/12/2009 | CA2396052C Increased lysine production by gene amplification |
| 05/12/2009 | CA2284079C Immunotoxins and methods of inducing immune tolerance |
| 05/12/2009 | CA2272338C Immunization of infants |
| 05/12/2009 | CA2244195C Pin m iii gene in white pine |
| 05/12/2009 | CA2213254C Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism |
| 05/12/2009 | CA2201940C Method of treating diabetes mellitus using kgf |
| 05/12/2009 | CA2157864C Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 05/12/2009 | CA2141430C Nucleic acid sequence amplification |
| 05/09/2009 | CA2611540A1 Sugar chain-containing albumin, production method thereof and use thereof |
| 05/09/2009 | CA2610098A1 Production of recombinant human hemoglobin using pichia yeast |
| 05/07/2009 | WO2009059305A2 Red fluorescent proteins with enhanced bacterial expression, increased brightness and reduced aggregation |
| 05/07/2009 | WO2009059254A2 Methods for the economical production of biofuel precursor that is also a biofuel from biomass |
| 05/07/2009 | WO2009059253A2 Methods for the economical production of biofuel from biomass |
| 05/07/2009 | WO2009059078A2 Method of genetically altering and producing allergy free cats |
| 05/07/2009 | WO2009058956A1 Signal sequences and co-expressed chaperones for improving protein production in a host cell |
| 05/07/2009 | WO2009058947A2 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 05/07/2009 | WO2009058927A1 Zymomonas with improved ethanol production in medium containing concentrated sugars and acetate |
| 05/07/2009 | WO2009058907A2 Targeting micrornas for the treatment of liver cancer |
| 05/07/2009 | WO2009058679A1 Streptomyces protease |
| 05/07/2009 | WO2009058518A1 Use and production of neutral metallproteases in a serine protease-free background |
| 05/07/2009 | WO2009058413A1 Generation of human embryonic stem-like cells using intronic rna |
| 05/07/2009 | WO2009058335A1 Major qtls conferring resistance of corn to fijivirus |
| 05/07/2009 | WO2009058326A1 Uses of a glycoprotein vi (gpvi) inhibitor |
| 05/07/2009 | WO2009058304A1 Uncoupling of dna insert propagation and expression of protein for phage display |
| 05/07/2009 | WO2009057944A2 Polymerase chain reaction product-cloning vector suitable to its easy production and method for producing the same |
| 05/07/2009 | WO2009057843A1 A novel canine influenza virus and vaccine therefore |
| 05/07/2009 | WO2009057831A1 Nuclear reprogramming method |
| 05/07/2009 | WO2009057813A1 Method for high-level secretion and production of protein |
| 05/07/2009 | WO2009057812A1 Organic-inorganic hybrid nano particle composed of nucleic acid conjugate having polyethylene glycol bound thereto and calcium phosphate |
| 05/07/2009 | WO2009057790A1 Medicine and medical instrument containing osteogenic and chondrogenic protein |
| 05/07/2009 | WO2009057757A1 Base sequence determination program, base sequence determination system and base sequence determination method |